Division of Neurobiology, Department of Neurology and Neuroscience, Weill Cornell Medical College, 407 East 61th Street, New York, NY 10065, United States.
Neuroscience. 2012 Dec 27;227:10-21. doi: 10.1016/j.neuroscience.2012.07.050. Epub 2012 Jul 31.
The ventral pallidum (VP) is a major recipient of inhibitory projections from nucleus accumbens (Acb) neurons that differentially express the reward (enkephalin) and aversion (dynorphin)-associated opioid peptides. The cannabinoid-1 receptor (CB1R) is present in Acb neurons expressing each of these peptides, but its location in the VP is not known. To address this question, we used electron microscopic dual immunolabeling of the CB1R and either dynorphin 1-8 (Dyn) or Met(5)-enkephalin (ME) in the VP of C57BL/6J mice, a species in which CB1R gene deletion produces a reward deficit. We also used similar methods to determine the relationship between the CB1R and N-acylphosphatidylethanolamine (NAPE)-hydrolyzing phospholipase D (NAPE-PLD), an anandamide-synthesizing enzyme located presynaptically in other limbic brain regions. CB1R-immunogold was principally localized to cytoplasmic endomembranes and synaptic or extrasynaptic plasma membranes of axonal profiles, but was also affiliated with postsynaptic membrane specializations in dendrites. The axonal profiles included many single CB1R-labeled axon terminals as well as terminals containing CB1R-immunogold and either Dyn or ME immunoreactivity. Dually labeled terminals comprised 26% of all Dyn- and 17% of all ME-labeled axon terminals. Both single- and dual-labeled terminals formed mainly inhibitory-type synapses, but almost 16% of these terminals formed excitatory synapses. Approximately 60% of the CB1R-labeled axonal profiles opposed or converged with axon terminals containing NAPE-PLD immunoreactivity. We conclude that CB1Rs in the mouse VP have subcellular distributions consistent with on demand activation by endocannabinoids that can regulate the release of functionally opposed opioid peptides and also modulate inhibitory and excitatory transmission.
腹侧苍白球(VP)是从伏隔核(Acb)神经元接收抑制性投射的主要部位,这些神经元分别表达与奖励(脑啡肽)和厌恶(强啡肽)相关的阿片肽。大麻素 1 型受体(CB1R)存在于表达这两种肽的 Acb 神经元中,但在 VP 中的位置尚不清楚。为了解决这个问题,我们使用电子显微镜双重免疫标记 CB1R 与 VP 中的 Dyn 或 Met(5)-脑啡肽(ME),在 CB1R 基因缺失产生奖励缺陷的 C57BL/6J 小鼠中,使用了类似的方法来确定 CB1R 与 N-酰基磷酸乙醇胺(NAPE)-水解磷脂酶 D(NAPE-PLD)之间的关系,NAPE-PLD 是一种位于其他边缘脑区突触前的合成大麻素的酶。CB1R-免疫金主要定位于细胞质内膜和轴突突起的突触或 extrasynaptic 质膜,但也与树突中的突触后膜特化有关。轴突突起包括许多单独的 CB1R 标记的轴突末梢,以及包含 CB1R-免疫金和 Dyn 或 ME 免疫反应性的末梢。双标记末梢占所有 Dyn 标记的轴突末梢的 26%,占所有 ME 标记的轴突末梢的 17%。单标记和双标记的末梢主要形成抑制型突触,但其中近 16%的末梢形成兴奋性突触。大约 60%的 CB1R 标记的轴突突起与含有 NAPE-PLD 免疫反应性的轴突末梢相对或汇聚。我们的结论是,小鼠 VP 中的 CB1R 具有亚细胞分布,与内源性大麻素的按需激活一致,内源性大麻素可以调节功能相反的阿片肽的释放,也可以调节抑制性和兴奋性传递。